Device Trial Radar · NCT06717451
PS230005 Control-IQ 1.5 Post-Approval Study
Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
144
Actual
Start
Jan 30, 2025
Primary completion
Aug 10, 2026
Study completion Aug 10, 2026
Sponsor
- Lead sponsor
- Tandem Diabetes Care, Inc.Public (TNDM)
- Sponsor type
- Industry
- Collaborators
- University of California, San Diego
- First posted
- Dec 5, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 2 years, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This 522 post-market surveillance study is a single-arm, decentralized prospective observational cohort study designed to collect safety data on Control-IQ technology v1.5 in children with type 1 diabetes ages 2 to \<6 years old. Participants will use Control-IQ technology v1.5 for 12 months in the real-world setting.
Conditions
- Type 1 Diabetes
Interventions
Control-IQ Technology v1.5Device
Tandem t:slim X2 insulin pump or Tandem Mobi insulin pump with Control-IQ technology v1.5. Every month participants will receive a survey to complete assessments including any severe hypoglycemia or diabetic ketoacidosis events experienced since the prior assessment. Participants will also complete surveys related to patient reported outcomes at baseline, 6 months, and 12 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence Rates of Severe Hypoglycemia (SH)Time frame: 12 months
- Incidence Rates of Diabetic Ketoacidosis (DKA)Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tandem Diabetes Care
San Diego, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.